As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Animal models of human diseases refer to animal experimental objects and related experimental materials established in the process of biomedical research that simulate human diseases.
•Clinically research on trauma, poisoning, tumor, etc. cannot be repeated in human body, and many scientific data must not be collected by causing human to suffer;
•As a substitute for humans, animals can be repeatedly observed under specific experimental conditions designed by humans, and animals can be sacrificed to obtain required animal tissues and organs.
• Risks, hazards and ethical issues arising from human experiments are avoided.
•Clinically hereditary, immune, metabolic and endocrine, blood and other diseases have a low incidence, and can replicate relevant animal models for research.
•Clinically tumors, chronic bronchitis, atherosclerosis and other diseases have a long incubation period and a long course of disease, which can reach decades.
• Diseases with long incubation periods, long duration and low morbidity
•Diseases are complex and are related to the patient's age, gender, constitution, heredity, and environment.
• When replicating animal models, animals of the same strain, sex, age, and body weight can be selected, and the microbial control (infection of pathogens) and experimental environment standards are also completely consistent;
• Therefore, other influencing factors can be excluded to make the experimental results more accurate and in-depth. Methodological comparability can be increased.
Animal models, as "replicas" of human diseases, can be based on experimental needs: • Samples are easily available • Analytical experiments are simplified.
•Classified by cause:
–Spontaneous animal model
–Induced animal model
– Genetically engineered animal model
• System-wide classification
– Basic pathological process of disease: inflammation, tumor, shock
– Animal models of diseases of various systems: cardiovascular, respiratory, digestive, occupational diseases
• Sort by model type
– Whole animals, isolated organs and tissues, cell lines, etc.
1. The effect of model-causing factors on the replication of animal models;
2. The influence of animal factors on the replication of animal models (standardized experimental animals for wild animals and domestic animals);
3. The influence of experimental technical factors on the replication of animal models;
4. The influence of environmental factors and nutritional factors on replicating animal models.
•(1) Similarity and comparability
•(2) Repeatability
•(3) Reliability
•(4) Applicability and controllability
•(5) Ease of operation and economy
• No animal model can completely replicate human disease, and the correctness of model experiment conclusions is only relative, and must ultimately be verified in humans.
• Keep the model animal as minimal as possible and with the least disturbance;
• The advanced degree of animal evolution does not mean that all organs and functions are close to the degree of human beings; inbred animals cannot be used blindly;
• Search literature and consult whether animals and conditions required for animal experiments are feasible, understand the experience accumulated by predecessors, and avoid waste of human and material resources caused by low-level repetition or blind movement without scientific basis.
The following is the animal model of Medicilon human diseases compiled by the editor for you. For the latest model information, please contact us.
Medicilon provides a variety of effective animal models to test the effectiveness of drugs according to customer needs. Experimental animals include non-human primates, dogs, mice, rats, rabbits, guinea pigs, nude mice and other species. At present, we have established a number of effective animal tumor models, which have been verified by various parties and tested in long-term practice. At the same time, our staff's rich experience and solid theoretical foundation can flexibly develop and establish various customized tumor disease models according to customer's customized requirements to meet customer needs. See more.
Cancer Type | Cell Line |
Breast cancer | BT-474,HCC1569,HCC1954,HCC70,JIMT-1,MCF-7,MDA-MB-231,MDA-MB-468,MX-1,SUM149PT,ZR-75-1,HCC1806 |
Colon cancer | COLO 205,DLD-1,HCT 116,HCT-15,HT-29,LIM-1215,LOVO,LS 174T,NCI-H508,RKO,SW480,SW620 |
Endometrium | AN3 CA,HEC-1-A |
Gastric | Hs746T,NCI-N87,SNU-16,MKN45 |
Glioblastoma | U-87MG,U-87 MG-Red-Fluc(PE),LN-229 |
Thyroid gland medullary | TT |
Hepatocellular | Hep G2,HuH-7 |
Leukemia | CCRF-CEM,HEL,HL-60,K-562,MV-4-11,THP-1,Karpas-299,MOLT-4,MOLM13 |
Lung | A-549,Calu-1,Calu-3,Calu-6,HCC827,MSTO-211H,NCI-H1299,NCI-H1650,NCI-H1975,NCI-H2122,NCI-H2228,NCI-H292,NCI-H358,NCI-H460,NCI-H520,NCI-H526,NCI-H69,NCI-H727,PC-9,NCI-H1581,NCI-H3122 |
Lymphoma | SU-DHL-4,DB,SU-DHL-6,Mino,Daudi,Jeko-1,Raji,TMD-8,WSU DLCL2,DOHH2,OCI-LY19,OCI-LY10,MM.1S,RPMI-8226,OPM2 |
Melanoma | A-375 |
Myeloma | MM.1S,NCI-H929,RPMI-8226,OPM-2 |
Neuroblastoma | SH-SY5Y |
Ovary | A2780,OVCAR-3,SK-OV-3 |
Pancreatic | AsPC-1,Bx PC-3,Capan-1,Capan-2,CFPAC-1,HPAF-II ,MIA PaCa-2,PANC-1,SU.86.86 |
Pharynx | FaDu |
Prostate | DU 145,PC-3 |
Renal | 786-O,OS-RC-2,A498 |
Skin | A-431 |
Urinary Bladder | RT4 |
Medicilon provides various effective animal models (renal failure model, anemia animal model, gastric acid secretion animal model, gastric ulcer model, etc.) according to the needs of customers to test the effectiveness of drugs. Conventional digestive system diseases include: gastric acid secretion, gastric ulcer, renal failure, etc., animal experiments are carried out through rats. See more.
Diseases | Models | Animals |
Renal failure | Nephrectomy (5/6) | Rats |
Anaemia | Renal failure-induced | Rats |
Iron deficiency anemia | Rats | |
Gastric acid secretions | Pylori ligation | Rats |
Histamine-induced | Rats | |
Gastric ulcer | Ethanol-induced | Rats |
Non-steroidal anti-inflammatory drug-induced models | Rats | |
Cold water stress-induced | Rats | |
Chronic, acetic acid-induced | Rats | |
Reflux esophagitis-induced | Rat | |
Ulcerative colitis (UC) | Trinitrobenzene sulfonic acid (TNBS)-induced | Rats |
Dextran sulfate sodium (DSS)-induced | Rats/mice |
Medicilon provides a variety of effective endocrine disease models and metabolic disease animal models to test the effectiveness of drugs according to customer needs. Conventional endocrine diseases and metabolic diseases include: diabetes, obesity, dyslipidemia, etc. Animal experiments are carried out through rats, hamsters, etc. See more.
Diseases | Models | Animals |
Obesity and diabetes | Streptozotocin-induced | Rats/mice |
Spontaneous | Mice (db/db, ob/ob) | |
Spontaneous | ZDF rats | |
High-fat and high-sugar diet-induced | Mice | |
Hyperuricemia | Potassium oxonate-induced | Rats/mice |
UA-induced | Mice | |
Hypoxanthine-induced | Mice | |
Adenine- and ethambutol-induced | Rats | |
Liver fibrosis | Bile duct ligation | Rats |
TAA-induced | Rats | |
Composite factor method-induced | Rats | |
ConA-induced | Mice | |
Porcine serum-induced | Rats | |
Lipid abnormality | High fat/cholesterol/fructose diet-induced | Hamster |
Hereditary atherosclerosis (APOE mice + high-fat diet) | APOE mice | |
Non-alcoholic fatty liver (NAFLD, NAFL, NASH) | Hereditary atherosclerosis (APOE mice) | APOE mice |
Non-alcoholic fatty liver | Rats | |
High-fat diet (HFD) | Rats/mice, hamsters | |
Methionine- and choline-deficient diet (MCD) | Mice | |
Composite factor-induced | Rats | |
Thrombus | Arteriovenous bypass thrombosis | Rats/mice |
Carrageenan-induced tail vein thrombosis | Mice | |
Deep vein thrombosis | Rats | |
Carotid artery thrombosis | Rats/mice |
Medicilon provides a variety of effective inflammatory disease models and immune disease animal models according to customer needs to test the effectiveness of drugs. Conventional inflammatory and immune diseases include: acute inflammation, arthritis, experimental allergic encephalomyelitis, etc. Animal experiments are carried out in rats and mice. See more.
Diseases | Inflammatory and Immunological Disease Models | Animals |
Arthritis | Chronic infectious arthritis (CIA) | Mice/rats |
Adjuvant induced-arthritis (AIA) | Rats | |
Pristane-induced arthritis (PIA) | Rats | |
Carrageenan-induced arthritis | Rats | |
Experimental allergic encephalomyelitis (EAE) | Mice | |
Psoriasis | Estrogen-induced vaginal epithelium mitosis | Mice |
Tail scales | Mice | |
IL-23-induced auricle epidermal dysplasia | Mice | |
Imiquimod-induced | Mice | |
Propranolol-induced | Guinea pigs | |
Atopic dermatitis and eczema | Dinitrofluorobenzene (DNFB)-induced | Mice |
Dinitrochlorbenzene + OX-induced | Mice | |
Phorbol ester-induced | Mice | |
Acute inflammation | Toe swelling | Rats/mice |
Auricle swelling | Mice | |
Capillary permeability test | Rats/mice | |
Granuloma proliferation | Rats |
Medicilon provides various effective animal models (depression animal model, Parkinson's disease animal model, psychotic animal model, etc.) according to the needs of customers to test the effectiveness of drugs. Conventional neurological diseases include: mental illness, Parkinson's disease, depression, pain (central), etc., through animal experiments such as rats and guinea pigs. See more.
Diseases | Nervous System Disease Models | Animals |
Anti-depressant | Inhibition of 5-HT, NA and DA brain synaptosome uptake (sample selection and IC 50 Determination) | Rats |
Forced swimming test (rats/mice, Noduls, video analysis) | Rats/mice | |
Tail suspension test (mice, Noduls, video analysis) | Mice | |
5-HTP-induced head twitch potentiation | Mice | |
Reserpine-induced ptosis | Mice | |
Yohimbine toxicity enhancement test | Mice | |
High-dose apomorphine antagonism | Mice | |
Chronic mild unpredictable stimulation (CUMS) in rats | Rats | |
New environment eating inhibition test | Rats/mice | |
MAO-A, MAO-B activity test | Mice | |
Protective effects on hippocampal neurons of newborn rats (glutamate injury, hydrogen peroxide injury, glucose and hypoxia injury, and dexamethasone injury, among others) | Newborn rats | |
Effect on synthesis and secretion of BDNF in SH-SY5Y cells | SH-SY5Y cells | |
Anticonvulsant test | Yohimbine toxicity enhancement test | Mice |
Pentylenetetrazole-induced seizure | Mice | |
Dicentime-induced seizure | Mice | |
Picrotoxin-induced seizure | Mice | |
Sedative-hypnotic and anti-anxiety tests | Synergistic effect with pentobarbital drugs | Mice |
Effect on subthreshold hypnotic dose of barbital | Mice | |
Re-sleep test | Mice | |
Open field test (rats/mice, camera monitoring and software processing for whole process) | Rats/mice | |
Elevated plus maze test | Rats | |
Shuttle box test (full camera monitoring and software processing) | Rats | |
Pain (with Von Frey hairs test) | Hot plate test | Rats/mice |
Tail-flick test | Rats/mice | |
Heat radiation test | Rats/mice | |
Tenderness test | Rats/mice | |
Von Frey hairs | Rats/mice | |
Acetic acid-induced writhing test | Mice | |
Formalin-induced test | Rats/mice | |
CFA-induced pain | Rats/mice | |
Carrageenan-induced pain | Rats/mice | |
LPS-induced pain | Rats/mice | |
Selective spinal nerve ligation (L5/L6) | Rats/mice | |
Sciatic nerve injuries (SNI) | Rats/mice | |
Pain induced by diabetes, incision, and cancer | Rats/mice | |
Anti-dementia tests | Acquired memory impairment (6-channel video analysis of the step-down test) | Mice |
Memory consolidation impairment (6-channel video analysis of the step-down test) | Mice | |
Memory retrieval impairment (6-channel video analysis of the step-down test) | Mice | |
Light-dark transition testing (4-channel video analysis) | Mice | |
Acquired memory impairment (Morris water maze video analysis) | Rats | |
Acetylcholinesterase Activity | Mice | |
D-galactose | Mice | |
New object recognition testing | Rats | |
APP/PS1 (Morris water maze, Cognition Wall) | Transgenic mice | |
In vitro testing | Cell level, molecular biology | |
Anti-schizophrenia | MK801-induced schizophrenia with positive symptoms | Mice |
MK801-induced schizophrenia with negative symptoms | Mice | |
Ketamine-induced schizophrenia with negative symptoms | Mice | |
Catalepsy | Rats | |
Lower lip retraction | Rats | |
Phencyclidine-induced activity enhancement | Rats |
Contact us
Email: marketing@medicilon.com